A glimpse into viral warfare: decoding the intriguing role of highly pathogenic coronavirus proteins in apoptosis regulation

Coronaviruses employ various strategies for survival, among which the activation of endogenous or exogenous apoptosis stands out, with viral proteins playing a pivotal role. Notably, highly pathogenic coronaviruses such as SARS-CoV-2, SARS-CoV, and MERS-CoV exhibit a greater array of non-structural proteins compared to low-pathogenic strains, facilitating their ability to induce apoptosis via multiple pathways. Moreover, these viral proteins are adept at dampening host immune responses, thereby bolstering viral replication and persistence. This review delves into the intricate interplay between highly pathogenic coronaviruses and apoptosis, systematically elucidating the molecular mechanisms underpinning apoptosis induction by viral proteins. Furthermore, it explores the potential therapeutic avenues stemming from apoptosis inhibition as antiviral agents and the utilization of apoptosis-inducing viral proteins as therapeutic modalities. These insights not only shed light on viral pathogenesis but also offer novel perspectives for cancer therapy.

COVID-19, caused by SARS-CoV-2, emerged in late 2019 and has become a global pandemic.By the end of 2023, there have been over 770 million reported cases and over 6.9 million deaths worldwide [4].Previous large-scale coronavirus outbreaks include SARS in 2002 (caused by SARS-CoV) and MERS in 2012 (caused by MERS-CoV).The cumulative number of infections for SARS and MERS was a approximately 8,000 [5] and 2,600 [6], respectively, with cumulative death toll of 774 [5] and 936 [6].

Apoptosis signal transduction
Apoptosis, a programmed cell death process, was originally proposed by J.F. Kerr in 1972 [26].The classical apoptosis is primarily categorized into three pathways based on the origin of the apoptotic signal: the endogenous endoplasmic reticulum (ER) stress pathway, the endogenous DNA damage pathway and the exogenous death receptor pathway.
Endogenous apoptosis mainly includes ER stress pathway and DNA damage pathway.When DNA damage (such as DNA double-strand break) occurs, DNA Fig. 1 Phylogenetic tree of highly pathogenic coronavirus (red), low-pathogenic coronavirus (blue) and the other SARS-related coronavirus.Reference sequences of representative coronaviruses include phylogenetic analysis was performed with the CLC program by the neighbor-joining method on the basis of the Kimura two-parameter model damage response (DDR) kinases ataxia-telangiectasia mutated (ATM), ATM-and Rad3-Related (ATR), DNA-dependent protein kinase (DNA-PK) are activated [27], and then a large amount of H2AX is rapidly phosphorylated at Ser-139 to produce phosphorylated histone H2AX (γH2AX) and bind to the damage sites [28], further activating p53 to phosphorylation, and promoting apoptosis by regulating the transcription of apoptosis-related genes (Fig. 3A).When unfolded protein response (UPR) and other factors induce ER stress, the protein kinase RNA-like endoplasmic reticulum kinase (PERK), inositol requiring enzyme 1α (IRE1α), and activating transcription factor 6 (ATF6) pathways are activated, resulting in enhanced C/EBP homologous protein (CHOP) expression and endogenous apoptosis (Fig. 3B).In response to signals such as DNA damage and ER stress, pro-apoptotic BH3-only proteins (BAD, BID, BIM, PUMA, NOXA, etc.) competitively bind to anti-apoptotic proteins (BCL-2, BCL-xL, MCL-1), releasing pro-apoptotic proteins (BAX, BAK, BOK) from antiapoptotic proteins [29].Free pro-apoptotic proteins form oligomers, leading to their activation and translocation to the outer mitochondrial membrane, forming channels.These channels cause mitochondrial outer membrane permeabilization (MOMP), resulting in the release of cytochrome C from the intermembrane space of mitochondria into the cytoplasm.Cytochrome C works with procaspase-9 and apoptotic protease activating factor 1 (APAF1) to form apoptosomes, which activates caspase-9.Then, activated caspase-9 cleaves procaspase-3, generating caspase-3.Caspase-3 further cleaves the DNA repair enzyme poly ADP-ribose polymerase (PARP), leading to DNA repair dysregulation and eventually triggering endogenous apoptosis [30][31][32][33][34] (Fig. 3).
The exogenous pathway relies on the activation of death receptors on the cell surface.When extracellular death ligands (such as FasL, TNF and TRAIL) bind to death receptors (Fas, TNFR1, TRAILR1, TRAILR2), a death-inducing signaling complex (DISC) containing the intracellular death domain of the death receptor, Fasassociating death domain protein (FADD)/ TNFR1-associated death domain protein (TRADD) and caspase-8 was formed.Caspase-8 is activated through oligomerization and subsequently, cleaves procaspase-3 to generate caspase-3, eventually exogenous apoptosis.Activated caspase-8, on the other hand, cleaves BH3-interacting domain death agonist (BID) into truncated BID (tBID), promotes the translocation of tBID from the cytosol to the mitochondria, which contribute to MOMP, ultimately leading to apoptosis [30][31][32]34] (Fig. 3A).
In conclusion, apoptosis is regulated by complex signal transduction pathways involving both endogenous and exogenous pathways.Understanding the mechanisms and interactions involved in apoptosis signal transduction is crucial for unraveling the intricate processes underlying cell death and survival and developing novel therapeutic strategies targeting apoptosis-related diseases.

Apoptosis and highly pathogenic coronaviruses: exploring the role of apoptosis in coronavirus pathogenesis
Traditionally, apoptosis has been regarded as a means for host cells to rescue themselves and facilitate viral clearance [35,36].However, compelling evidence is emerging to suggest that apoptosis can act as a double-edged sword, capable of benefiting both DNA and RNA viruses in promoting their self-replication [37,38].
Remarkably, it has been observed that caspase-deficient cells exhibit a heightened antiviral ability compared to normal cells [39].Mitochondrial stress is one of the ways that SARS-CoV-2 activates the cyclic GMP-AMP synthase-stimulator of interferon gene (cGAS-STING) signaling pathway, which causes mitochondrial dysfunction and releases mitochondrial DNA (mtDNA) from the mitochondria into the cytoplasm [40], resulting in upregulating of type I interferon (IFN-I) expression.In order to antagonize the antiviral effect of interferon, the virus employs a strategy by enhancing the apoptosis signal, activating caspase-3 and caspase-7, both of which play crucial roles downstream in the apoptotic pathway [41].These activated caspases not only cleave and inactivate IFN-I [42], but also promote mtDNA degradation, and inhibit the activation of cGAS-STING signaling pathway [41,43].Consequently, the virus evades the surveillance and clearance by the host immune system, establishing a favorable environment for its survival.
In the long-term struggle between viruses and hosts, some viruses have developed strategies to manipulate cellular processes.For highly pathogenic coronaviruses such as MERS-CoV, SARS-CoV, and SARS-CoV-2 mentioned above, inducing apoptosis is an important way to promote viral replication, aggravate tissue and organ damage, and motivate the development of diseases [37,38].
Studies have demonstrated that apoptosis is associated with lung injury, multi-organ failure in COVID-19 patients [44][45][46].Notably, SARS-CoV-2 predominantly induces apoptosis in respiratory epithelial cells rather than necrosis.This preference is evidenced by the abundance of apoptotic cells and scarcity of necrotic cells following invasion of human respiratory epithelial cells [47].This characteristic may reflect the virus's "cleverness" in adopting immune "silencing" apoptosis as a survival strategy given that apoptosis is more suitable for the virus's survival than necrosis, which can trigger excessive production of inflammatory factors.Following SARS-CoV-2 infection, the virus persists longer in the nasal mucosa compared to the lungs, with lower production of inflammatory factors [48].This is due to nasal mucosal epithelial cells primarily undergoing apoptosis after viral infection, whereas in the lungs, the apoptosis rate is lower and the pyroptosis rate is higher [48], while apoptosis of immune silence is more conducive to viral replication.Notably, the virus is predominantly present in superficial epithelial cells in the early stages of infection, and gradually invades submucosal cells as the disease progresses [48].Therefore, apoptosis may favor the spread of the virus from nasal mucosal epithelial cells to submucosal cells, that is, apoptosis can promote the spread of SARS-CoV-2.
Moreover, evidence suggests that SARS-CoV-2 triggers apoptosis in lung epithelial cells, destroys the alveolar capillary barrier, thereby promoting the development of pulmonary edema and acute respiratory distress syndrome (ARDS), and aggravating lung injury in patients with COVID-19, resulting in high mortality [35,[49][50][51][52]. Patients with severe COVID-19 were more likely to develop apoptosis than those with mild symptoms, highlighting the direct relationship between apoptosis levels and severity and mortality of COVID-19 patients [53].During SARS-CoV-2 infection, the apoptosis ratio of B lymphocytes, T lymphocytes [54,55] and monocytes [53] is also elevated.This coupled with impaired phagocytosis and anti-inflammatory function of macrophages and monocytes after phagocytosing apoptosis cells [56], particularly in severe clinical cases, suggests that enhanced apoptosis of immune cells may contribute to the severe clinical symptoms of COVID-19 patients.Additionally, SARS-CoV-2-induced apoptosis in β pancreatic cells contributes to abnormal glucose metabolism, which aggravates diabetes [57].In summary, apoptosis aggravates multiple organ failure and microcirculation disorders through various mechanisms, leading to higher patient mortality rates and poor clinical outcomes.[58][59][60].Due to elevated dipeptidyl peptidase-4 (DPP4) receptor expression on T lymphocytes, they become more vulnerable to MERS-CoV infection, triggering apoptosis.MERS-CoV targets lymphoid organs like the spleen and tonsils, infecting T lymphocytes at various developmental stages, leading to extensive apoptosis and subsequent lymphocyte depletion.This immune system paralysis exacerbates viral infection, culminating in a severe prognosis for patients [59].Yeung ML et al. discovered that MERS-CoV induces apoptosis in kidney cells by upregulating the expression of smad family member 7 (Smad7) and fibroblast growth factor 2 (FGF2), thus facilitating viral release and dissemination of infection in kidneys and other tissues.Consequently, the incidence of renal failure in MERS patients surpasses that of other human coronavirus infections [58].Notably, MERS-CoV uses caspase-6, a component of the apoptosis cascade, to cleave the N protein, producing small fragments that act as interferon antagonists and suppress the host immune response, thus promoting replication [38].The inhibition of caspase-6 can attenuate MERS-CoV replication in human lung tissue and human intestinal organoids, and also improve the pathological changes of the lung in vivo caused by the virus [38].

MERS-CoV activates both endogenous and exogenous apoptotic pathways, leading to extensive apoptosis of bronchial epithelial cells, renal cells, macrophages, dendritic cells and other cells, resulting in high morbidity and mortality among MERS patients
Furthermore, SARS-CoV infection triggers significant apoptosis in lung epithelial cells [61,62], lymphocytes [63,64], liver [65], thyroid [66] and kidney [67] cells.Microarray analysis of host genes showed that the expression of 13 pro-apoptotic genes was up-regulated after SARS-CoV infection, while only 3 pro-apoptotic genes were up-regulated after infection with the lowpathogenic coronavirus HCoV-229E.Thus, highly pathogenic coronaviruses enhance pathogenicity by inducing apoptosis.It is with regret that cross-sectional comparisons of the apoptosis-inducing capacity of highly pathogenic coronaviruses are still lacking in the field.Further study of this may help us understand the important role of apoptosis in the pathogenesis of highly pathogenic coronaviruses.

Mechanism and biological significance of apoptosis modulated by highly pathogenic coronavirus structural proteins
Highly pathogenic coronavirus structural proteins, including S, E, M and N proteins, play critical roles in cell invasion, virus particle synthesis, release, and also modulation of cell apoptosis [68][69][70]93] (Table 1).
SARS-CoV-2 E protein has been shown to induce apoptosis in periodontal ligament fibroblasts [77], although the mechanism of action remains to be elucidated (Fig. 3A).Studies have reported that SARS-CoV E proteins can trigger ER stress [63,78] and promote mitochondria-mediated apoptosis by sequestering the anti-apoptotic protein B-cell lymphoma-extra large (BCL-xL) onto the ER membrane [63] (Fig. 3A).Remarkably, SARS-CoV E protein has been reported to hinder the process of apoptosis.For example, they can downregulate the IRE1α signaling pathway associated with unfolded proteins, without affecting the PERK and ATF6 signaling pathways (Fig. 3B).Ultimately, this reduction in apoptosis occurs [79].The fact that the same viral protein has opposite effects on apoptosis may indicate that the viral protein performs different functions at different stages of the viral life cycle.SARS-CoV-2 M protein induces apoptosis in lung epithelial cells through mitochondria, and can inhibit BOK ubiquitination and stabilize its levels by interacting with the BH2 domain of BOK's endodomain in the absence of BAX and BAK, ultimately promoting BOK mitochondrial localization [52] (Fig. 3A).BOK can directly mediate the increase of mitochondrial membrane permeability and ultimately activate mitochondrial pathway-induced apoptosis [80].In addition, SARS-CoV-2 M protein can also inhibit the activation of PDK1-Akt signaling and induce caspase-dependent apoptosis by interacting with 3-phosphoinositide-dependent protein kinase 1 (PDK1), while the SARS-CoV-2 N protein can specifically enhance the interaction between M protein and PDK1, thereby enhancing apoptosis induced by M protein [81][82][83] (Fig. 3A).The synergistic effect of M proteins and N proteins to enhance their respective levels of induced apoptosis has also been found in SARS-CoV [82,84] (Fig. 3A).Meanwhile, the MERS-CoV M protein can interact with the ER marker glucose regulated protein 78kD (GRP78), disrupt the binding of GRP78 and PERK, specifically activate the PERK pathway, further activate the expression of downstream pro-apoptotic genes (Fig. 3B), enhance self-replication, aggravate host lung injury, and increase the susceptibility to apoptosis inducer, Etoposide.In addition, PERK inhibitor significantly inhibits MERS-CoV replication [37].
The same viral protein can result in different effects on apoptosis, which may be related to the different effects of apoptosis on different stages of the viral life cycle.Understanding these mechanisms and the significance of coronavirus structural proteins-induced apoptosis is crucial in developing therapeutics and interventions against highly pathogenic coronaviruses.
SARS-CoV ORF3b can induce G0/G1 arrest and apoptosis [111,112] (Fig. 3A), while the function of SARS-CoV-2 ORF3d, which was previously mistaken for SARS-CoV-2 ORF3b, remains unknown.SARS-CoV ORF6 is known to mediate ER stress and JNK-dependent apoptosis [113] (Fig. 3B).However, further research is needed to determine whether SARS-CoV-2 ORF6 can induce apoptosis.It should be noted that MERS-CoV ORF6 acts as the E protein and will not be discussed further in this context.SARS-CoV-2 ORF7a interacts with the anti-apoptotic protein BCL-xL through the C-terminal amino acid residues Lys117 and Lys 119, recruiting BCL-xL to the ER to activate ER stress and induce apoptosis (Fig. 3A).Concurrently, ORF7a induces ER stress through the PERK-elF2α-CHOP pathway, suppressing the expression of endogenous BCL-xL and thereby augmenting apoptosis (Fig. 3B).The ubiquitination of ORF7a Lys119 can diminish its interaction with BCL-xL, impeding the aggregation of BCL-xL in the ER, and consequently preventing ER stress and inhibiting apoptosis [97].Remarkably, SARS-CoV ORF7a exhibits a similar pro-apoptotic mechanism to SARS-CoV-2 ORF7a [114].Moreover, SARS-CoV ORF7a can also activate the p38 MAPK pathway, inhibit the host cell translation process and induce apoptosis [115] (Fig. 3B).

However, the induction of apoptosis by SARS-CoV
ORF7b has yet to be established.
Some studies suggest that SARS-CoV-2 ORF9c may enhance the transcription of apoptosis-related genes in human cardiomyocytes by influencing adenosine 5'-triphosphate (ATP) metabolism, which may lead to heart disease induced by COVID-19 [106] (Fig. 3A).It has been observed that the administration of Ivermectin and Meclozine can restore cellular ATP levels and ameliorate SARS-CoV-2 ORF9c-induced cardiomyocyte apoptosis and dysfunction [106].
In summary, although some viral proteins are still unknown whether they can regulate apoptosis, existing reports have shown that non-structural proteins encoded by highly pathogenic coronaviruses induce apoptosis and promote viral survival through multiple mechanisms.In vitro experiments have demonstrated that apoptosis inhibitors can significantly inhibit the replication of highly pathogenic coronaviruses [37].This further underscores the critical role of apoptosis in the survival of these virus.

The important role of expressing more non-structural proteins by highly pathogenic coronaviruses in virus-induced cell apoptosis
Highly pathogenic coronaviruses exhibit heightened replication efficiency and transmissibility compared to their low-pathogenic counterparts [47], potentially due to the increased abundance of non-structural proteins they encode (Fig. 2B).While research on the induction of apoptosis by low-pathogenic coronaviruses is limited [134][135][136], existing studies suggest that highly pathogenic coronaviruses promote the expression of more pro-apoptotic genes [134][135][136].Non-structural proteins by highly pathogenic coronaviruses plays a pivotal role in inducing cell apoptosis through multiple mechanisms.Importantly, innate immunity is also impaired during the process, which benefits the virus's replication and dissemination within the host, leading to exacerbated pathology and disease severity (Table 2).Understanding this mechanism is essential for comprehending the virulence and pathogenesis of highly pathogenic coronaviruses, offering insights for the development of targeted therapeutic interventions aimed at mitigating virusinduced cell apoptosis and reducing disease severity.Ultimately, unraveling the intricacies of non-structural protein-mediated apoptosis sheds light on potential avenues for effective intervention against highly pathogenic coronaviruses and related viral diseases.

Application and limitations of apoptosis inhibitors in antiviral research
The use of apoptosis inhibitors has shown promise in inhibiting coronavirus-induced apoptosis and attenuating viral replication.To explore the potential of apoptosis inhibitors as antiviral drugs, with a focus on their application in the field of coronaviruses is meaningful.Additionally, the limitations and the need for further research and improvement in the clinical application of apoptosis inhibitors against viruses should be discussed.
Highly pathogenic coronaviruses use caspase family members to promote viral survival and immune evasion.In vitro and in vivo experiments have proved that caspase members have the function of antagonizing key proteins of innate immune pathway and helping viral immune evasion, and caspase inhibitors effectively inhibit the replication of coronavirus, alleviate lung damage and excessive immune response in mice caused by viral infection, and significantly improve the survival rate [37,38].It is worth noting that caspase-6 inhibitors did not affect the replication of influenza virus (H1N1) or enterovirus (EV-A71), and it is possible that apoptosis has a significant effect on the replication of coronavirus, but not on other viruses [38].Despite this, different inhibitors of the apoptotic pathway exhibit varying efficacy against different coronaviruses.For example, caspase-6 and PERK inhibitors have a significant therapeutic effect on MERS-CoV-infected mice but have poor efficacy on SARS-CoV and SARS-CoV-2 infected mice [37,38].Understanding the specific caspase proteins involved in viral replication and identifying corresponding inhibitors are crucial for the treatment of highly pathogenic coronaviruses.
In current coronavirus research, inhibiting apoptosis activation through apoptosis inhibitors has shown promise in curbing viral replication.Certain PARP inhibitors, including Olaparib [137][138][139], Stenoparib [140], and CVL218 [141,142], exhibit antiviral effects against highly pathogenic coronaviruses.They effectively control viral replication, mitigate inflammatory responses, and alleviate pathological changes.Combining PARP inhibitors with Remdesivir enhances their efficacy in inhibiting coronaviruses, presenting a significant potential in treating highly pathogenic coronavirus infections.While some apoptosis inhibitors have demonstrated efficacy in animal and cell studies, their clinical application as antiviral drugs lacks established protocols and requires further refinement and research.Furthermore, the susceptibility of other mammals to coronavirus infection and their reliance on caspase remains unclear.Considering the reports that swine acute diarrhea syndrome coronavirus (SADS-CoV) may spread across species and become the next zoonotic coronavirus [143], the study on investigating the role of caspase in mammalian susceptible coronaviruses could aid in timely response to outbreaks and facilitate the development of effective therapeutic drugs.
However, the clinical application of apoptosis inhibitors for the treatment of viral infections is currently limited due to associated side effects.Studies have indicated that certain caspase proteins inhibit the production of IFN-I, a key mediator of antiviral immune responses.It has been shown that caspase-9, caspase-3, and caspase-7 can inhibit the production of IFN-I mediated by the cGAS-STING signaling pathway [41,43].In human cells, caspase-3 suppresses IFN-I in a manner independent of mtDNA, reduces cytokine release by cleaving cGAS, mitochondrial antiviral signaling protein (MAVS), and interferon regulatory factor 3 (IRF3) [39], and silences apoptotic cell immunity, as is caspase-7 in mice cells [39].As a consequence, the suppression of caspases's function may probably lead to excessive immune activation and inflammatory cytokine storm, posing a risk during the treatment of patients with coronavirus infection.Therefore, addressing the issue of potential side effects is crucial in the development of apoptosis inhibitors for antiviral therapy.

Conclusion remarks
Apoptosis plays an important role in both physiological processes and the pathogenesis of highly pathogenic coronaviruses, as well as an important driver of disease progression.More and more studies have proved that apoptosis serves not only as a means for the host to reduce viral replication and facilitate viral clearance, but also as a strategy employed by viruses to antagonize the host immune system surveillance and response, as well as exploit apoptosis and its components to suppress the production of antiviral factors, bolster viral replication, and augment infectivity.
While SARS-CoV-2 infection has been linked to various modes of cell death, including apoptosis, pyroptosis, and ferroptosis [45,48,144,145], studies indicate that the lungs have a higher proportion of pyroptosis and necroptosis, while the upper respiratory tract, with a greater viral load, tends towards apoptosis.[48,146].This observatiobsuggests that apoptosis imay be more conducive to viral replication than pyroptosis and necroptosis.Moreover, the latest in vivo experimental evidence suggests that necroptosis has no significant effect on viral transmission, disease pathology, or early host immune responses, independent of disease progression [147].Consequently, targeting mixed lineage kinase domain-like pseudokinase (MLKL), a key protein in the necroptotic pathway, with antiviral drugs may yield limited effectiveness.High pathogenic strains have evolved additional nonstructural proteins that regulate apoptosis in tandem with the encoded structural proteins.Simultaneously, these non-structural proteins promote viral survival in a way that antagonize innate immunity.Although not all virus-encoded proteins induce apoptosis, many reported apoptosis-related proteins indeed trigger this process, and each protein is presumed to play a role in viral replication regulation.This phenomenon likely stems from the necessity, during the early stages of virus invasion, to maintain host cell integrity to facilitate optimal conditions for viral replication.Structural proteins introduced into cells during viral invasion play a role in inhibiting apoptosis at this stage.However, upon completing replication, the virus aims to release a multitude of viral particles from the cell through apoptosis, thereby dampening the host immune response and diminishing the likelihood of elimination.Consequently, numerous virus-encoded proteins are involved in regulating apoptosis induction.Different viral proteins possess varying abilities to induce apoptosis at distinct stages of viral replication, targeting diverse pathways to ensure apoptosis of virus-infected cells.Highly pathogenic coronaviruses rely on a larger array of non-structural proteins to modulate apoptosis, a process pivotal in augmenting viral replication, exacerbating tissue and organ damage, and advancing disease progression.In summary, apoptosis contributes to multiple organ failure and microcirculation disorders through diverse mechanisms, resulting in elevated patient mortality rates and unfavorable clinical outcomes.The high pathogenicity of coronavirus-encoded proteins in efficiently inducing apoptosis has garnered interest in their potential use for treating small cell lung cancer.Specifically, the S proteins of SARS-CoV-2 have been shown to induce apoptosis and can successfully induce tumor cell apoptosis in mice models when administered intranasally [148].However, it is regrettable that this has only been verified in animal experiments, and further research is necessary to bolster the validation of clinical trials and eventually apply them to clinical practice.It has also been reported that in vitro experiments, lentiviral particles Gag-CASP8-VLPs, carrying activated caspase-8 and constructed using the VSV G protein (VSV-G) as the vector, can enter breast cancer cells and inhibit tumor cell growth [149].In the future, small molecule drugs that mimic the structure of the key functional domains of highly pathogenic coronavirus proteins may be applied to target tumor cells and induce tumor cell death, providing a new perspective in tumor treatment.
Here, we systematically summarized the mechanism and biological significance of apoptosis induced by highly pathogenic coronaviruses structural and non-structural proteins, caspase-mediated survival strategies in highly pathogenic coronaviruses and the potential of apoptosis inhibitors in antiviral research.Further study should focus on the investigating the network-based research on viral proteins and key compositions in the apoptosis pathway.Furthermore, combining this knowledge with other antiviral medicines may help inhibit viral infection and alleviate tissue and organ damage.By simulating how highly pathogenic coronavirus-encoded proteins activate apoptosis, researchers can identify or design small molecule drugs with the ability to target and activate apoptosis in tumor cells.These efforts could unlock new insights into the biological function of highly pathogenic coronavirus proteins and the regulatory mechanism of apoptosis.Such in-depth research holds great significance in our understanding of the pathogenic mechanisms of coronaviruses, the development of effective treatment strategies, and the prevention of new infectious diseases.

Fig. 2
Fig. 2 General structural pattern diagram and genome of coronavirus.A, Coronavirus particles include E, M, N, S, genomic RNA and secondary components such as ORF3a, ORF7a, ORF7b, ORF9b of SARS-CoV and ORF3a, ORF7a of SARS-CoV-2.B, Schematic diagram of the genomic organization and encoded proteins of SARS-related coronavirus.The highly pathogenic coronaviruses (red) encode more non-structural proteins

Fig. 3
Fig. 3 Overview of apoptosis activation by proteins encoded by highly pathogenic coronaviruses.A, Exogenous death receptor apoptotic pathway and intrinsic DNA damage-induced apoptosis pathway.B, Intrinsic ER stress-induced apoptosis pathway.The majority of proteins encoded by highly pathogenic coronaviruses enhance the activity of pro-apoptotic proteins (indicated by red arrows) and suppress the function of anti-apoptotic proteins (indicated by blue arrows).Certain structural proteins (depicted in blue) exhibit the capability to inhibit apoptosis

Table 1
Summary of apoptosis modulated by structural proteins of highly pathogenic coronaviruses

Table 2
Summary of apoptosis induced by non-structural proteins of highly pathogenic coronaviruses